| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,834 |
15,365 |
$1.67M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,790 |
12,564 |
$929K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12,685 |
12,345 |
$652K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,143 |
5,041 |
$517K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,326 |
4,234 |
$429K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,991 |
3,874 |
$377K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,102 |
3,034 |
$337K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,246 |
7,954 |
$333K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,244 |
4,948 |
$153K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,363 |
8,844 |
$141K |
| 99188 |
|
4,479 |
4,374 |
$74K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,106 |
2,005 |
$72K |
| 94760 |
|
9,519 |
8,261 |
$72K |
| 94010 |
|
1,975 |
1,836 |
$50K |
| 99381 |
|
515 |
470 |
$47K |
| 96127 |
|
8,657 |
8,148 |
$44K |
| 99429 |
|
5,320 |
3,396 |
$43K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,287 |
3,299 |
$43K |
| 97802 |
|
10,659 |
10,402 |
$37K |
| 94667 |
|
1,540 |
1,477 |
$32K |
| 94664 |
|
1,700 |
1,624 |
$28K |
| 96160 |
|
9,714 |
9,365 |
$27K |
| 92587 |
|
573 |
558 |
$25K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
140 |
136 |
$19K |
| 85018 |
|
6,095 |
5,967 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,076 |
1,010 |
$17K |
| 96161 |
|
4,033 |
3,794 |
$15K |
| 92552 |
|
2,683 |
2,642 |
$14K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
491 |
471 |
$9K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
9,957 |
9,763 |
$8K |
| 99173 |
|
6,623 |
6,471 |
$6K |
| 80061 |
Lipid panel |
512 |
476 |
$5K |
| 82465 |
|
1,109 |
1,088 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
375 |
361 |
$4K |
| 95012 |
|
184 |
171 |
$3K |
| 92567 |
|
143 |
143 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
13 |
$2K |
| 99401 |
|
94 |
87 |
$2K |
| 90651 |
|
1,323 |
1,294 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
3,740 |
3,577 |
$2K |
| 99383 |
|
12 |
12 |
$1K |
| 0071A |
|
42 |
40 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$1K |
| 99051 |
|
76 |
73 |
$1K |
| 0072A |
|
27 |
26 |
$1K |
| 0001A |
|
16 |
15 |
$490.00 |
| 81003 |
|
182 |
169 |
$420.40 |
| 90716 |
|
1,464 |
1,439 |
$373.34 |
| 1005F |
|
2,176 |
2,047 |
$324.68 |
| 90707 |
|
1,314 |
1,287 |
$221.00 |
| 90620 |
|
2,197 |
2,131 |
$188.21 |
| 5250F |
|
1,898 |
1,809 |
$186.00 |
| 36416 |
|
4,788 |
4,664 |
$125.40 |
| 90715 |
|
398 |
387 |
$63.00 |
| 90686 |
|
2,626 |
2,554 |
$59.69 |
| 90671 |
|
355 |
326 |
$50.00 |
| 91300 |
|
28 |
27 |
$42.13 |
| 92551 |
|
12 |
12 |
$8.05 |
| 90681 |
|
1,584 |
1,527 |
$0.00 |
| 90700 |
|
330 |
321 |
$0.00 |
| 90670 |
|
2,803 |
2,740 |
$0.00 |
| 90648 |
|
1,903 |
1,840 |
$0.00 |
| 90633 |
|
1,484 |
1,453 |
$0.00 |
| 83655 |
|
1,613 |
1,588 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
272 |
263 |
$0.00 |
| 90734 |
|
1,193 |
1,162 |
$0.00 |
| 99072 |
|
3,900 |
3,544 |
$0.00 |
| 90685 |
|
48 |
48 |
$0.00 |
| 90647 |
|
926 |
904 |
$0.00 |
| 90688 |
|
436 |
428 |
$0.00 |
| 99000 |
|
522 |
499 |
$0.00 |
| 90723 |
|
2,384 |
2,311 |
$0.00 |
| 90696 |
|
377 |
372 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
49 |
47 |
$0.00 |
| 91307 |
|
58 |
53 |
$0.00 |